Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 0115-5445

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 0115-5445). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Bupropion Hydrochloride Extended Release Tablets S 1)

Chemical Structure (Bupropion Hydrochloride Extended Release Tablets S 1)
Chemical structure of Bupropion Hydrochloride, showing its aromatic ring with chlorine and methyl substitutions, and the hydrochloride salt component.*
FDA Label Image

A (Bupropion Hydrochloride Extended Release Tablets S 2)

A (Bupropion Hydrochloride Extended Release Tablets S 2)
Label for buPROPion HCl Extended-Release Tablets (SR) 200 mg, film-coated oral tablets by Amneal Pharmaceuticals of New York LLC. The label states the product contains 200 mg of bupropion hydrochloride per tablet, packaged as 60 tablets. It includes usage warnings, pharmacist dispensing instructions, storage conditions, and a QR code for the medication guide. The label features the Amneal logo and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.